Menu
Focal One® - Investor Relations
About Focal One
Focal One® is a registered trademark of EDAP TMS.
EDAP TMS (NASDAQ: EDAP) is the global leader in therapeutic ultrasound. EDAP TMS develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology. EDAP TMS has an active operating worldwide network of corporate offices, subsidiaries, and distribution partners. By investing in Research & Development, EDAP TMS is committed to partnering with world-class research laboratories and internationally renowned medical institutions. Over the course of the last 40 years, EDAP TMS has developed a robust patent portfolio based on its innovative technologies.
Minimum 15 minutes delayed.
Source:
JAN 13, 2025
Investor Presentation
Positioned for Growth
The Global Leader in Innovation and Delivery of Advanced Ultrasound Technologies for both the Diagnosis and Treatment of Diseases.
Financial Results
EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures
AUSTIN, Texas, January 13, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced preliminary record Focal One System sales for the fourth quarter of calendar year 2024..
AUSTIN, Texas, January 13, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced preliminary record Focal One System sales for the fourth quarter of calendar year 2024..